The MITRE Trial Protocol: a Study to Evaluate the Microbiome As a Biomarker of Efficacy and Toxicity in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
BMC Cancer(2022)
Key words
Microbiome,Immunotherapy,Melanoma,Renal cancer,Non-small cell lung cancer,Biomarker,Immune checkpoint inhibitor,Efficacy,Toxicity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined